These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32090179)

  • 21. Homology modeling and molecular docking simulation of some novel imidazo[1,2-a]pyridine-3-carboxamide (IPA) series as inhibitors of Mycobacterium tuberculosis.
    Abdullahi M; Adeniji SE; Arthur DE; Haruna A
    J Genet Eng Biotechnol; 2021 Jan; 19(1):12. PubMed ID: 33474593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug resistance of Mycobacterium tuberculosis isolates from tuberculosis lymphadenitis patients in Ethiopia.
    Biadglegne F; Tessema B; Sack U; Rodloff AC
    Indian J Med Res; 2014 Jul; 140(1):116-22. PubMed ID: 25222786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnitude of gene mutations conferring drug resistance in mycobacterium tuberculosis isolates from lymph node aspirates in ethiopia.
    Biadglegne F; Tessema B; Rodloff AC; Sack U
    Int J Med Sci; 2013; 10(11):1589-94. PubMed ID: 24046537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-Line Anti-Tubercular Drug Resistance of Mycobacterium tuberculosis in IRAN: A Systematic Review.
    Pourakbari B; Mamishi S; Mohammadzadeh M; Mahmoudi S
    Front Microbiol; 2016; 7():1139. PubMed ID: 27516756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing drug resistance of Mycobacterium tuberculosis isolates in a medical center in northern Taiwan.
    Su WJ; Feng JY; Huang CC; Perng RP
    J Formos Med Assoc; 2008 Mar; 107(3):259-64. PubMed ID: 18400612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A modified decision tree approach to improve the prediction and mutation discovery for drug resistance in Mycobacterium tuberculosis.
    Deelder W; Napier G; Campino S; Palla L; Phelan J; Clark TG
    BMC Genomics; 2022 Jan; 23(1):46. PubMed ID: 35016609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance pattern of multi-drug resistant strains of Mycobacterium tuberculosis and characteristics of patients with multi-drug resistant tuberculosis.
    Moisoiu A; Mitran CI; Mitran MI; Huhu MR; Ioghen OC; Gheorghe AS; Tampa M; Georgescu SR; Popa MI
    Roum Arch Microbiol Immunol; 2016; 75(1-2):25-31. PubMed ID: 29616530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach.
    Uddin R; Zahra NU; Azam SS
    Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis.
    Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
    Bioorg Chem; 2021 Jan; 106():104486. PubMed ID: 33276981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and computational studies of benzimidazole derivatives as new antitubercular agents.
    Yalcin-Ozkat G; Ersan RH; Ulger M; Ulger ST; Burmaoglu S; Yildiz I; Algul O
    J Biomol Struct Dyn; 2023 Apr; 41(7):2667-2686. PubMed ID: 35132948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioisosteric modification of Linezolid identified the potential
    Girase R; Ahmad I; Patel H
    J Biomol Struct Dyn; 2024; 42(4):2111-2126. PubMed ID: 37097976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
    Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
    J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterium tuberculosis resistance pattern against first-line drugs in patients from urban area.
    Cucunawangsih ; Wiwing V; Widysanto A; Lugito NP
    Int J Mycobacteriol; 2015 Dec; 4(4):302-5. PubMed ID: 26964812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco.
    Chaoui I; Sabouni R; Kourout M; Jordaan AM; Lahlou O; Elouad R; Akrim M; Victor TC; El Mzibri M
    J Infect Dev Ctries; 2009 May; 3(4):278-84. PubMed ID: 19759491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution and Pattern of Anti-Tubercular Drug Resistance in Patients with Pulmonary Tuberculosis in Mymensingh Region of Bangladesh.
    Hasan MS; Hossain MA; Paul SK; Nasreen SA; Ahmed S; Haque N; Hasan M; Khan MK; Das BR; Biswas JP; Islam A
    Mymensingh Med J; 2022 Oct; 31(4):1102-1107. PubMed ID: 36189558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ubiA (Rv3806c) encoding DPPR synthase involved in cell wall synthesis is associated with ethambutol resistance in Mycobacterium tuberculosis.
    He L; Wang X; Cui P; Jin J; Chen J; Zhang W; Zhang Y
    Tuberculosis (Edinb); 2015 Mar; 95(2):149-54. PubMed ID: 25547657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method.
    Caleffi-Ferracioli KR; Maltempe FG; Siqueira VL; Cardoso RF
    Tuberculosis (Edinb); 2013 Nov; 93(6):660-3. PubMed ID: 24083948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of isoimperatorin, alone and in combination, against Mycobacterium tuberculosis.
    Guo N; Wu J; Fan J; Yuan P; Shi Q; Jin K; Cheng W; Zhao X; Zhang Y; Li W; Tang X; Yu L
    Lett Appl Microbiol; 2014 Apr; 58(4):344-9. PubMed ID: 24330002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.